Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Myelin membrane lipids are the primary structural components of the myelin sheath, a specialized multi-layered membrane that insulates axons in the central and peripheral nervous systems (StatPearls, 2023). Comprising approximately 70-80% of the myelin dry weight, these lipids—including cholesterol, galactocerebroside, and sulfatide—are essential for saltatory conduction, which significantly increases the speed of nerve impulse transmission (PubMed, PMID: 22403187). In neurodegenerative and demyelinating diseases like Multiple Sclerosis, these lipids are often the target of autoimmune attacks or metabolic deficiencies, leading to axonal vulnerability and functional loss (Mayo Clinic, 2024). Therapeutic strategies targeting myelin lipids focus on either protecting existing structures from inflammatory degradation or stimulating oligodendrocyte-mediated remyelination to restore lipid bilayers (Nature Reviews Neurology, 2021). Modern pharmacological approaches include sphingosine-1-phosphate (S1P) receptor modulators like Fingolimod and small molecules like Clemastine that promote the differentiation of oligodendrocyte precursor cells into mature, lipid-producing cells (The Lancet, 2017).
Modulation of sphingosine-1-phosphate receptors to prevent lymphocyte egress and promotion of oligodendrocyte precursor cell differentiation to restore lipid membranes.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myelin membrane lipids.